Acuitas Therapeutics Video Update
Acuitas Therapeutics is the global leader in the field of lipid nanotechnology. We specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNP). We work with partners to develop new therapies to address unmet clinical needs.
In our latest video, President & CEO Dr. Thomas Madden provides a brief overview of Acuitas, our proprietary LNP, and our work on COMIRNATY®, the Pfizer/BioNTech COVID-19 vaccine.